Corrigendum: Antithyroglobulin Antibody Variation During Follow-Up Has a Good Prognostic Value for Preoperative Antithyroglobulin Antibody-Positive Differentiated Thyroid Cancer Patients: A Retrospective Study in Southwest China

Corrigendum: Antithyroglobulin Antibody Variation During Follow-Up Has a Good Prognostic Value for Preoperative Antithyroglobulin Antibody-Positive Differentiated Thyroid Cancer Patients: A Retrospective Study in Southwest China

Bibliographic Details
Main Authors:	Qianhui Liu, Mengting Yin, Guixing Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-04-01
Series:	Frontiers in Endocrinology
Subjects:	thyroid cancer prognosis antithyroglobulin biomarker DTC (differentiated thyroid cancer)
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2022.899184/full

Similar Items

Antithyroglobulin Antibody Variation During Follow-Up Has a Good Prognostic Value for Preoperative Antithyroglobulin Antibody-Positive Differentiated Thyroid Cancer Patients: A Retrospective Study in Southwest China
by: Qianhui Liu, et al.
Published: (2021-12-01)

Association of antithyroglobulin antibody with iodine nutrition and thyroid dysfunction in Nepalese children
by: Binaya Tamang, et al.
Published: (2019-07-01)

In properly selected patients with differentiated thyroid cancer, antithyroglobulin antibodies decline after thyroidectomy and their sole presence should not be an indication for radioiodine ablation
by: Luis Felipe Zavala, et al.
Published: (2019-04-01)

Clinical outcome of patients with differentiated thyroid cancer and raised antithyroglobulin antibody levels: a retrospective study
by: Manish Ora, et al.
Published: (2021-04-01)

Stimulated thyroglobulin and pre-ablation antithyroglobulin antibody products can predict the response to radioiodine therapy of TgAb-positive differentiated thyroid cancer patients: a retrospective study
by: Na Han, et al.
Published: (2023-09-01)

Combination of Stimulated Thyroglobulin and Antithyroglobulin Antibody Predicts the Efficacy and Prognosis of 131I Therapy in Patients With Differentiated Thyroid Cancer Following Total Thyroidectomy: A Retrospective Study
by: Mengjiao Pan, et al.
Published: (2022-04-01)

Evaluation of Thyroid Hormones and AntiThyroglobulin Antibodies among Sudanese Polycystic Ovarian Syndrome Patients
by: Rofida Abuobaida KAMIL, et al.
Published: (2020-10-01)

Lung Recurrence of Papillary Thyroid Cancer Diagnosed With Antithyroglobulin Antibodies After 10 Years From Initial Treatment
by: David Viola, et al.
Published: (2018-10-01)

Predictivity of stimulated serum thyroglobulin and antithyroglobulin antibodies for the efficacy of thyroid remnant ablation on patients with differentiated thyroid carcinoma
by: Narin Nasiroglu Imga, et al.
Published: (2016-12-01)

Clinical significance of thyroglobulin autoantibodies enhancement in patients with differentiated thyroid cancer after thyroidectomy and radioiodine therapy
Published: (2013-09-01)

Dynamic Changes in Antithyroperoxidase and Antithyroglobulin Antibodies Suggest an Increased Risk for Abnormal Thyrotropin Levels
by: Yongze Li, et al.
Published: (2020-08-01)

Study of thyroid disorders in vitiligo
by: Lalchamliani Khiangte, et al.
Published: (2023-01-01)

Prognostic Factors in the Survival Rate of Patients with Differentiated Thyroid Cancer
by: Moulod Abbaszadeh, et al.
Published: (2020-07-01)

Accuracy of papillary thyroid cancer prognostic nomograms: a systematic review
by: Maria Luisa Garo, et al.
Published: (2023-03-01)

Utility of recombinant human TSH stimulation test in the follow-up of patients with differentiated thyroid cancer depending on basal thyroglobulin results
by: Sandúa Amaia, et al.
Published: (2020-01-01)

Measuring thyroglobulin concentrations in patients with differentiated thyroid carcinoma
by: Savin Svetlana, et al.
Published: (2010-01-01)

Sorafenib in Metastatic Papillary Thyroid Carcinoma with <i>BRAF K601E</i> Mutation on Liquid Biopsy: A Case Report and Literature Review
by: Marianna Caterino, et al.
Published: (2022-05-01)

Prevalence of Thyroid Autoimmunity in Women with Recurrent Pregnancy Loss
by: Myrna Souraye Godines-Enriquez, et al.
Published: (2021-01-01)

Development of a pediatric differentiated thyroid carcinoma registry within the EuRRECa project: rationale and protocol
by: S C Clement, et al.
Published: (2023-02-01)

Utility of non-contrast Dual Energy Computed Tomography in diagnosis of differentiated thyroid cancer – two case study
by: Adam Daniel Durma, et al.
Published: (2023-04-01)

Delayed risk stratification system in pT1aN0/Nx DTC patients treated without radioactive iodine
by: Danuta Ga˛sior-Perczak, et al.
Published: (2017-09-01)

Analysis of risk factors and prognosis in differentiated thyroid cancer with focus on minimal extrathyroidal extension
by: Manuel Weber, et al.
Published: (2021-08-01)

Persistent Thyroid Carcinoma and Pregnancy: Outcomes in an Italian Series and Review of the Literature
by: Carla Colombo, et al.
Published: (2022-11-01)

Prevalence of hypothyroidism in type 2 diabetic female Kurdish subjects
by: Sarheed Jabar Muhammed, et al.
Published: (2018-01-01)

Evaluation of Antithyroid Antibodies in Aborting People from Obstetrics Clinic of Mahdieh Hospital at Shaheed Beheshti University
by: Maryam Bahrami Sharif, et al.
Published: (2009-09-01)

Secondary hormonal alterations in short-term severe hypothyroidism; in the focus: Apelin and copeptin
by: Marin Gergics, et al.
Published: (2022-09-01)

Preoperative Thyroid Peroxidase Antibody Predicts Recurrence in Papillary Thyroid Carcinoma: A Consecutive Study With 5,770 Cases
by: Weibin Wang, et al.
Published: (2022-05-01)

Facing Thyroid Nodules in Paediatric Patients Previously Treated with Radiotherapy for Non-Thyroidal Cancers: Are Adult Ultrasound Risk Stratification Systems Reliable?
by: Arnoldo Piccardo, et al.
Published: (2021-09-01)

Current Status and Challenges of US-Guided Radiofrequency Ablation of Thyroid Nodules in the Long Term: A Systematic Review
by: Stella Bernardi, et al.
Published: (2021-06-01)

On the Centennial of Vitamin D—Vitamin D, Inflammation, and Autoimmune Thyroiditis: A Web of Links and Implications
by: Leonidas H. Duntas, et al.
Published: (2022-11-01)

Coexistence of Hashimoto’s Thyroiditis in Differentiated Thyroid Cancer: Post-Operative Monitoring of Anti-Thyroglobulin Antibodies and Assessment of Treatment Response
by: Alessandra Donnici, et al.
Published: (2024-01-01)

GA genotype of the Arg280His polymorphism on the XRCC1 gene: Genetic susceptibility genotype in differentiated thyroid carcinomas?
by: Kirnap NG, et al.
Published: (2021-07-01)

Influence of chronic lymphocytic thyroiditis on the risk of persistent and recurrent disease in patients with papillary thyroid carcinoma and elevated antithyroglobulin antibodies after initial therapy
by: Marina Carvalho S. Côrtes, et al.
Published: (2018-07-01)

Radioactive iodine therapy strategies for distinct types of differentiated thyroid cancer: a propensity score–matched analysis
by: Honghao Guo, et al.
Published: (2023-08-01)

Outcomes of Patients With Metastatic Differentiated Thyroid Cancer After Excellent Response to Treatment
by: Chia-Jung Hsu, et al.
Published: (2022-06-01)

The association between thyroid-stimulating hormone and thyroid nodules, goiter and thyroid antibody positivity
by: Shaohan Li, et al.
Published: (2023-10-01)

The Prognostic Role of Postablative Non-Stimulated Thyroglobulin in Differentiated Thyroid Cancer
by: Szabina Szujo, et al.
Published: (2021-01-01)

Theranostic Options for Radioiodine-Refractory Differentiated Thyroid Carcinoma: Recent Advances, Challenges, and Road Ahead
by: Swayamjeet Satapathy, et al.
Published: (2022-07-01)

Clinical Analysis of Preoperative Anti-thyroglobulin Antibody in Papillary Thyroid Cancer Between 2011 and 2015 in Beijing, China: A Retrospective Study
by: Xiaomeng Jia, et al.
Published: (2020-07-01)

Association between hashimoto thyroiditis and differentiated thyroid cancer: A single-center experience
by: Federico Cappellacci, et al.
Published: (2022-07-01)